Danone executive

Danone executive

TATEBAYASHI, Japan - John Davison, president of the dairy products division of major French food conglomerate Danone, speaks during a press conference in Tatebayashi, Gunma Prefecture, on April 11, 2013. He said the company is reluctant to launch a hostile takeover bid for Japanese lactic drink maker Yakult Honsha Co., with which it has been in talks to boost its stake in Yakult.

  • Product Code
  • ILEA001181171
  • Registered date
  • 2013/4/11 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2013 Kyodo News
  • Media size
  • 1633 × 2511 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 448.48(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
          Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

          Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

          TOKYO, Japan - Tatsuo Higuchi, president of Otsuka Holdings Co., attends a press conference in Tokyo's Minato Ward on Dec. 2, 2014, on the planned acquisition by its subsidiary Otsuka Pharmaceutical Co. of California-based biopharmaceutical firm Avanir Pharmaceuticals Inc. for $3.54 billion through a tender offer to be followed by a merger. The Japanese nutrition product and drug manufacturer will pay $17 per Avanir share in the takeover bid through its U.S. subsidiary.
            Toray agrees on 1 tril. yen supply contract with Boeing

            Toray agrees on 1 tril. yen supply contract with Boeing

            TOKYO, Japan - Akihiro Nikkaku (L), president of Toray Industries Inc., shakes hands with John J. Tracy, chief technology officer of Boeing Co., at a press conference in Tokyo on Nov. 17, 2014. Toray said it has agreed on a new contract worth 1 trillion yen (about $8.7 billion) to supply carbon fiber for Boeing's jets and will begin talks to work together with the U.S. aircraft maker to lower the costs of the lightweight material.
              Coca-Cola to hike canned drink price in Japan

              Coca-Cola to hike canned drink price in Japan

              TOKYO, Japan - Tim Brett, president of Coca-Cola (Japan) Co., speaks at a press conference in Tokyo on Feb. 27, 2014. The beverage maker said it will raise the price of its canned drinks, including cokes and coffee sold in vending machines, by 10 yen to 130 yen in Japan when a sales tax hike in April takes effect.
                Coca-Cola to hike canned drink price in Japan

                Coca-Cola to hike canned drink price in Japan

                TOKYO, Japan - Tim Brett, president of Coca-Cola (Japan) Co., speaks at a press conference in Tokyo on Feb. 27, 2014. The beverage maker said it will raise the price of its canned drinks, including cokes and coffee sold in vending machines, by 10 yen to 130 yen in Japan when a sales tax hike in April takes effect.
                  Canon group net profit up 2.6%

                  Canon group net profit up 2.6%

                  TOKYO, Japan - Toshizo Tanaka, executive vice president of Canon Inc., releases the company's earnings results for the year ended Dec. 31, 2013, at a press conference in Tokyo on Jan. 29, 2014. The maker of printers, photocopiers and cameras said its group net profit for the just-ended business year rose 2.6 percent from the previous year to 230.48 billion yen.
                    Shiseido names new president

                    Shiseido names new president

                    TOKYO, Japan - Masahiko Uotani, outside chief marketing advisor of Shiseido Co., smiles during a press conference in Tokyo on Dec. 24, 2013, after the cosmetics maker announced he will become its new president effective April 1, 2014, replacing Shinzo Maeda.
                      Shiseido names new president

                      Shiseido names new president

                      TOKYO, Japan - Masahiko Uotani (L), outside chief marketing advisor of Shiseido Co., shakes hands with the cosmetics maker's president, Shinzo Maeda, during a press conference in Tokyo on Dec. 24, 2013. Shiseido announced that Uotani will become its new president effective April 1, 2014, replacing Maeda.